Suki secures $90m Series E to expand healthcare AI beyond documentation
Healthier Capital, Crosslink Capital and Hercules Capital join the investor group as Suki extends its clinical AI business across health systems and software partners.
A broader role in healthcare workflows
Suki announced the financing on October 13 as it moves into clinical reasoning, revenue-cycle and operational tasks. The company has built its business around clinical conversations and is seeking a wider role in the work that follows an appointment.
Healthier Capital’s Aman Mahajan joins the board with the financing. The announcement also names Venrock, Flare Capital Partners, Hedosophia, Philips Ventures and Zoom Ventures as returning participants.
Growth through software partners
Suki says its application serves more than 450 healthcare organizations and over 30 technology partners embed its technology. Partner revenue has grown more than tenfold in two years, according to the company, making distribution through other vendors an increasingly important part of the business.
The company reports that revenue doubled in 2025 and projects similar growth for 2026. That second figure remains a forecast; the financing announcement does not disclose absolute revenue.
Use of funds
Develop healthcare AI technology
Expand integrations and the partner ecosystem
Grow the commercial organization